Logo

TransTech Pharma Selects Genedata s High Throughput Screener

Dec 14, 2005

NEW YORK, Dec. 14 (GenomeWeb News) - TransTech Pharma signed a multi-year license for Genedata's high throughput screening-analysis software, Genedata said today.

 

TransTech Pharma scientists will use the software, Genedata Screener, to enhance their efforts to develop small molecules as therapeutics for treating human diseases. Screener has been integrated with TransTech Pharma's IT and screening infrastructure to automate data quality evaluation and standardize the analysis of compound bioactivity.

 

Financial details were not disclosed.

Breaking News
The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.